Palatin Technologies, Inc.

Direct answer

Palatin Technologies, Inc. is publicly traded on AMEX under the ticker PTN.

Palatin Technologies, Inc. is a biopharmaceutical firm specializing in the creation of precise, receptor-targeting treatments for various medical conditions throughout the United States. Its flagship product is Vyleesi, a melanocortin receptor (MCr) agonist prescribed for premenopausal women experiencing hypoactive sexual desire disorder. The company's pipeline also includes oral PL8177, a selective MC1r agonist...

Can you invest in Palatin Technologies, Inc.?

Yes. Palatin Technologies, Inc. is publicly traded on AMEX under the ticker PTN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Palatin Technologies, Inc.

Detailed equity research is provided by MarketSnap.